A detailed history of Legal & General Group PLC transactions in Bioventus Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 3,561 shares of BVS stock, worth $41,450. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,561
Holding current value
$41,450
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$3.96 - $6.93 $14,101 - $24,677
3,561 New
3,561 $20,000
Q1 2023

May 15, 2023

SELL
$1.07 - $2.95 $7,968 - $21,968
-7,447 Reduced 73.58%
2,674 $2,000
Q2 2022

Aug 22, 2022

BUY
$6.82 - $13.82 $50,222 - $101,770
7,364 Added 267.1%
10,121 $69,000
Q4 2021

Feb 14, 2022

BUY
$12.37 - $16.77 $13,940 - $18,899
1,127 Added 69.14%
2,757 $40,000
Q3 2021

Nov 15, 2021

BUY
$13.7 - $17.25 $11,220 - $14,127
819 Added 100.99%
1,630 $23,000
Q2 2021

Aug 12, 2021

BUY
$13.75 - $18.8 $1,526 - $2,086
111 Added 15.86%
811 $14,000
Q1 2021

May 17, 2021

BUY
$11.49 - $19.21 $8,043 - $13,447
700 New
700 $11,000

Others Institutions Holding BVS

About Bioventus Inc.


  • Ticker BVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 61,664,200
  • Market Cap $718M
  • Description
  • Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...
More about BVS
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.